These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22116347)

  • 1. A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens.
    Seidel UJ; Oliveira CC; Lampen MH; Hall Tv
    Cancer Immunol Immunother; 2012 Jan; 61(1):119-25. PubMed ID: 22116347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors.
    Doorduijn EM; Sluijter M; Querido BJ; Oliveira CC; Achour A; Ossendorp F; van der Burg SH; van Hall T
    J Clin Invest; 2016 Feb; 126(2):784-94. PubMed ID: 26784543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAP-ing into TIEPPs for cancer immunotherapy.
    Kiessling R
    J Clin Invest; 2016 Feb; 126(2):480-2. PubMed ID: 26784539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination.
    Chambers B; Grufman P; Fredriksson V; Andersson K; Roseboom M; Laban S; Camps M; Wolpert EZ; Wiertz EJ; Offringa R; Ljunggren HG; van Hall T
    Cancer Res; 2007 Sep; 67(18):8450-5. PubMed ID: 17875682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement.
    Marijt KA; Griffioen L; Blijleven L; van der Burg SH; van Hall T
    Cancer Immunol Immunother; 2022 Feb; 71(2):289-300. PubMed ID: 34142235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different expression levels of the TAP peptide transporter lead to recognition of different antigenic peptides by tumor-specific CTL.
    Durgeau A; El Hage F; Vergnon I; Validire P; de Montpréville V; Besse B; Soria JC; van Hall T; Mami-Chouaib F
    J Immunol; 2011 Dec; 187(11):5532-9. PubMed ID: 22025554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
    Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
    Front Immunol; 2019; 10():1505. PubMed ID: 31333652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1.
    van Hall T; Laban S; Koppers-Lalic D; Koch J; Precup C; Asmawidjaja P; Offringa R; Wiertz EJ
    J Immunol; 2007 Jan; 178(2):657-62. PubMed ID: 17202325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class I
    Marijt KA; Doorduijn EM; van Hall T
    Mol Immunol; 2019 Sep; 113():43-49. PubMed ID: 29627136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
    van Hall T; Wolpert EZ; van Veelen P; Laban S; van der Veer M; Roseboom M; Bres S; Grufman P; de Ru A; Meiring H; de Jong A; Franken K; Teixeira A; Valentijn R; Drijfhout JW; Koning F; Camps M; Ossendorp F; Kärre K; Ljunggren HG; Melief CJ; Offringa R
    Nat Med; 2006 Apr; 12(4):417-24. PubMed ID: 16550190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes.
    El Hage F; Durgeau A; Mami-Chouaib F
    Ann N Y Acad Sci; 2013 Apr; 1283():75-80. PubMed ID: 23302073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.
    Khanna R; Burrows SR; Moss DJ; Silins SL
    J Virol; 1996 Aug; 70(8):5357-62. PubMed ID: 8764046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
    Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
    J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.
    Sherritt M; Cooper L; Moss DJ; Kienzle N; Altman J; Khanna R
    Int Immunol; 2001 Mar; 13(3):265-71. PubMed ID: 11222495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAP-inhibitors from old world primate 1-herpesviruses and their use: WO2009008713.
    Raghavan M
    Expert Opin Ther Pat; 2010 Feb; 20(2):277-82. PubMed ID: 20100007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.
    Leibowitz MS; Andrade Filho PA; Ferrone S; Ferris RL
    Cancer Immunol Immunother; 2011 Apr; 60(4):525-35. PubMed ID: 21207025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trastuzumab mediated T-cell response against HER-2/neu overexpressing esophageal adenocarcinoma depends on intact antigen processing machinery.
    Milano F; Guarriera M; Rygiel AM; Krishnadath KK
    PLoS One; 2010 Aug; 5(8):e12424. PubMed ID: 20865050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises.
    Ashi MO; Mami-Chouaib F; Corgnac S
    Explor Target Antitumor Ther; 2022; 3(6):746-762. PubMed ID: 36654823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ T cell responses against TAP-inhibited cells are readily detected in the human population.
    Lampen MH; Verweij MC; Querido B; van der Burg SH; Wiertz EJ; van Hall T
    J Immunol; 2010 Dec; 185(11):6508-17. PubMed ID: 20980626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.
    Lu J; Celis E
    Cancer Res; 2000 Sep; 60(18):5223-7. PubMed ID: 11016651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.